8 Pathogenesis and Classification of Female Pattern Hair Loss

Sara Wasserbauer

Summary:

Female hair loss is a multifactorial disease, abounding with concomitant factors and mimics. With roughly 21 million women experiencing hair loss in the United States alone, and up to 80% of women experiencing noticeable hair loss by the age of 60 years, it is a significant problem that demands dedicated hair loss physicians. Most experts now agree that, unlike male pattern hair loss, androgens may not be the primary etiologic factor, other genetic and androgenetic influences are certainly present. Thus the term “female pattern hair loss” or “female hair loss” is preferred over “androgenetic alopecia.”

Key words

female - FPHL - androgenetic - classification

• 1 Olsen EA, Messenger AG, Shapiro J et al. Evaluation and treatment of male and female pattern hair loss.. J Am Acad Dermatol 2005; 52 (2) 301-311 PubMed

• 2 Olsen EA. Androgenetic alopecia. In: Olsen EA, ed. Disorders of Hair Growth: Diagnosis and Treatment. New York, McGraw-Hill, 1994:257–283

• 3 Smith MA, Wells RS. Male-type alopecia, alopecia areata, and normal hair in women; family histories. Arch Dermatol. 1964;89:95–98

• 4 Conrad F, Ohnemus U, Bodo E et al. Substantial sex-dependent differences in the response of human scalp hair follicles to estrogen stimulation in vitro advocate gender-tailored management of female versus male pattern balding.. J Investig Dermatol Symp Proc 2005; 10 (3) 243-246 PubMed

• 5 Paik JH, Yoon JB, Sim WY, Kim BS, Kim NI. The prevalence and types of androgenetic alopecia in Korean men and women. Br J Dermatol. 2001;145(1):95–99

• 6 Sanke S, Chander R, Jain A, Garg T, Yadav P. A comparison of the hormonal profile of early androgenetic alopecia in men with the phenotypic equivalent of polycystic ovarian syndrome in women.. JAMA Dermatol 2016; 152 (9) 986-991 PubMed

• 7 Franks S, White D, Gilling-Smith C, Carey A, Waterworth D, Williamson R. Hypersecretion of androgens by polycystic ovaries: the role of genetic factors in the regulation of cytochrome P450c17 alpha.. Baillieres Clin Endocrinol Metab 1996; 10 (2) 193-203 PubMed

• 8 Redler S, Tazi-Ahnini R, Drichel D et al. Selected variants of the steroid-5-alpha-reductase isoforms SRD5A1 and SRD5A2 and the sex steroid hormone receptors ESR1, ESR2 and PGR: no association with female pattern hair loss identified.. Exp Dermatol 2012; 21 (5) 390-393 PubMed

• 9 Riedel-Baima B, Riedel A. Female pattern hair loss may be triggered by low oestrogen to androgen ratio.. Endocr Regul 2008; 42 (1) 13-16 PubMed

• 10 Lizneva D, Gavrilova-Jordan L, Walker W, Azziz R. Androgen excess: investigations and management.. Best Pract Res Clin Obstet Gynaecol 2016; 37: 98-118 PubMed

• 11 Trüeb RM. Hormones and hair growth [in German].. Hautarzt 2010; 61 (6) 487-495 PubMed

• 12 Fischer TW, Hipler UC, Elsner P. Effect of caffeine and testosterone on the proliferation of human hair follicles in vitro.. Int J Dermatol 2007; 46 (1) 27-35 PubMed

• 13 Achilli C, Pundir J, Ramanathan P, Sabatini L, Hamoda H, Panay N. Efficacy and safety of transdermal testosterone in postmenopausal women with hypoactive sexual desire disorder: a systematic review and meta-analysis.. Fertil Steril 2017; 107 (2) 475-482 PubMed

• 14 Rosner W, Vesper H, , , , , , , , , , , , . Toward excellence in testosterone testing: a consensus statement.. J Clin Endocrinol Metab 2010; 95 (10) 4542-4548 PubMed

• 15 Ohnemus U, Uenalan M, Conrad F et al. Hair cycle control by estrogens: catagen induction via estrogen receptor (ER)-alpha is checked by ER beta signaling.. Endocrinology 2005; 146 (3) 1214-1225 PubMed

• 16 Arai A, von Hintzenstern J, Kiesewetter F, Schell H, Hornstein OP. In vitro effects of testosterone, dihydrotestosterone and estradiol on cell growth of human hair bulb papilla cells and hair root sheath fibroblasts.. Acta Derm Venereol 1990; 70 (4) 338-341 PubMed

• 17 Wehner G, Schweikert HU. Estrone sulfate source of estrone and estradiol formation in isolated human hair roots: identification of a pathway linked to hair growth phase and subject to site-, gender-, and age-related modulations.. J Clin Endocrinol Metab 2014; 99 (4) 1393-1399 PubMed

• 18 Niiyama S, Happle R, Hoffmann R. Influence of estrogens on the androgen metabolism in different subunits of human hair follicles. Eur J Dermatol. 2001;11(3):195–198

• 19 Price VH, Roberts JL, Hordinsky M et al. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia.. J Am Acad Dermatol 2000; 43 (5, Pt 1) 768-776 PubMed

• 20 Sawaya ME, Price VH. Different levels of 5-alpha-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia.. J Invest Dermatol 1997; 109 (3) 296-300 PubMed

• 21 Miller JA, Darley CR, Karkavitsas K, Kirby JD, Munro DD. Low sex-hormone binding globulin levels in young women with diffuse hair loss.. Br J Dermatol 1982; 106 (3) 331-336 PubMed

• 22 Olsen EA. Disorders of hair growth: diagnosis and treatment, 2nd ed. McGraw-Hill; 2003:305, 308–310

• 23 Olsen EA. Female pattern hair loss. J Am Acad Dermatol. 2001;45(3 Suppl):S70–S80

• 24 Nusbaum BP, Fuentefria S. Naturally occurring female hairline patterns. Dermatol Surg. 2009;35(6):907–913

• 25 The Cohen Hair Loss Severity Scale and Profile. The Hair Transplant Forum, November–December 2009

• 26 Harries M, Tosti A, Bergfeld W et al. Towards a consensus on how to diagnose and quantify female pattern hair loss - The ‘Female Pattern Hair Loss Severity Index (FPHL-SI)’.. J Eur Acad Dermatol Venereol 2016; 30 (4) 667-676 PubMed

• 27 Wikramanayake TC, Mauro LM, Tabas IA et al. Cross-section trichometry: a clinical tool for assessing the progression and treatment response of alopecia.. Int J Trichology 2012; 4 (4) 259-2 -64 PubMed